Magnum Ice Cream Plans About €110 Million Share Purchase for Employee Incentive Plans

The Magnum Ice Cream Company plans to acquire up to 6.6 million ordinary shares through forward purchase arrangements to cover certain obligations under its long-term incentive plans. At the share price referenced in its September 18 announcement, the company said that amount of stock is worth about €110 million. The shares are intended to be delivered to Magnum’s employee benefit trust rather than cancelled.

The announcement sets the maximum number of shares but leaves important execution details open. Magnum did not disclose counterparties, settlement dates, a fixed purchase price or a timetable for completing the purchases. Because the €110 million figure was described by reference to the current share price, it is an indicative value rather than a disclosed final cash cost.

On its official regulatory announcements page, Magnum said the forward purchases will be carried out in accordance with the EU Market Abuse Regulation and other applicable requirements. It also said further details will be provided. The stated purpose is therefore narrower than a conventional share buyback aimed at returning capital or cancelling stock: Magnum is sourcing shares for employee incentive obligations.

New plan follows a 5.4 million-share August tranche

The September plan comes immediately after Magnum completed a similar round of share purchases. On August 18, the company announced plans for forward contracts covering up to 5.5 million ordinary shares, worth about €90 million at the share price then prevailing. That earlier announcement gave the same purpose, covering obligations arising from long-term incentive plans, and said the shares were intended for the employee benefit trust.

Magnum then issued periodic updates as shares were acquired. By September 10, it said 5,401,973 ordinary shares had been purchased since the August announcement, completing that tranche. The final reported day, September 9, included 306,030 shares bought at an average price of €16.75604, for a total reported purchase amount of about €5.13 million for that day.

The new ceiling of 6.6 million shares is 1.1 million shares, or 20%, above the previous maximum. The euro figures from the two announcements should not be treated as fixed deal values, however. Magnum described both amounts using the share price at the time of each announcement, while the detailed updates for the August program reported actual daily prices and purchase amounts as the buying progressed.

The earlier program also shows how Magnum has handled disclosure around these purchases. It first announced a maximum share count and approximate value, then published execution updates with daily volumes, average prices and trading venues before declaring the tranche complete. The September 18 notice starts with the same broad framework, but Magnum has not yet published equivalent execution data for the new 6.6 million-share plan.

Employee benefit trust is the stated destination

The destination of the shares is important for understanding the purpose of the program. Magnum said the stock will be delivered to its employee benefit trust, which supports obligations connected with share-based employee incentives. The company did not say the shares will be retired, and it did not frame the purchase as a capital-return program.

That distinction matters because a share purchase connected with employee awards has a different objective from a buyback whose main purpose is to reduce shares outstanding or distribute surplus cash to shareholders. Here, Magnum is arranging a supply of shares that can be used to satisfy employee benefit obligations under the relevant plan terms. The September announcement does not establish how many awards will ultimately vest or be exercised, nor does it say how many of the acquired shares will eventually be transferred to individual participants.

Magnum also referred to “long-term incentive plans” in the plural and did not allocate the 6.6 million shares among named programs. That limits how far the announcement can be interpreted. The size of the purchase should not be assumed to match any single award grant or any one executive compensation plan unless the company provides that link in a later filing.

Foundation Plan shows the scale of Magnum’s equity incentives

One prominent part of Magnum’s equity framework is its Foundation Plan for Growth, a one-time co-investment plan established after the company’s demerger from Unilever and listing as an independent business. Magnum has described the plan as a way to require meaningful personal investment by participating senior leaders while tying matching option awards to longer-term shareholder returns.

A June 17 filing with the U.S. Securities and Exchange Commission said options were granted under the Foundation Plan on June 16. Magnum later reported 10,952,635 share options outstanding from that grant in its half-year results. The options vest in two equal portions after three and four years, subject to continued employment and a relative total shareholder return condition. The filing also reported exercise prices of €15.33, £13.23 and $17.82 depending on the relevant market.

A separate June registration statement covered up to 18.5 million ordinary shares that may be issued in connection with the Foundation Plan. That registration indicates the potential scale of the program, but it does not prove that the new 6.6 million-share forward purchase is being made specifically for the Foundation Plan. Magnum’s September 18 announcement did not identify a particular incentive program, so the two disclosures should not be treated as interchangeable.

The Foundation Plan itself received 77.37% support at Magnum’s May 7 annual general meeting. Because more than 20% of votes were cast against the resolution, the board later engaged with shareholders and governance bodies. In a September 17 update, one day before the new share-purchase announcement, Magnum said it would continue that engagement and provide further updates in its 2026 annual report.

For now, the confirmed development is the new purchase capacity: up to 6.6 million ordinary shares, with an indicative value of about €110 million at the referenced share price, intended for the employee benefit trust. Magnum has not yet disclosed the counterparties, final pricing or settlement schedule. Magnum said it will provide further details of the new purchases. During the prior tranche, those follow-up disclosures included daily share counts, average prices and trading venues before the company announced completion.